Literature DB >> 1556009

A new inhibitor of protein kinase C, RK-1409 (7-oxostaurosporine). I. Taxonomy and biological activity.

H Osada1, H Koshino, T Kudo, R Onose, K Isono.   

Abstract

A novel inhibitor of protein kinase C was found in the fermentation of a soil actinomycete, strain RK-1409. According to the taxonomic studies, the producing strain was designated as Streptomyces platensis subsp. malvinus RK-1409. The protein kinase C inhibitor, RK-1409 (7-oxostaurosporine) inhibited the morphological change of a human chronic erythroleukemia cell, K-562, induced by phorbol 12,13-dibutyrate (PDBu) at the concentration of 10 ng/ml. The concentration of 3 ng/ml inhibited the activity of protein kinase C in vitro. RK-1409 inhibited the cell cycle progression at G2 phase of K-562 cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1556009     DOI: 10.7164/antibiotics.45.189

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  11 in total

Review 1.  Thom Award Lecture. Trends in the search for bioactive microbial metabolites.

Authors:  S Omura
Journal:  J Ind Microbiol       Date:  1992-09

2.  Effect of UCN-01, a selective inhibitor of protein kinase C, on the cell-cycle distribution of human epidermoid carcinoma, A431 cells.

Authors:  S Akinaga; K Nomura; K Gomi; M Okabe
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

3.  Staurosporines disrupt phosphatidylserine trafficking and mislocalize Ras proteins.

Authors:  Kwang-jin Cho; Jin-Hee Park; Andrew M Piggott; Angela A Salim; Alemaheyu A Gorfe; Robert G Parton; Robert J Capon; Ernest Lacey; John F Hancock
Journal:  J Biol Chem       Date:  2012-11-02       Impact factor: 5.157

4.  Staurosporines decrease ORMDL proteins and enhance sphingomyelin synthesis resulting in depletion of plasmalemmal phosphatidylserine.

Authors:  Masashi Maekawa; Minhyoung Lee; Kuiru Wei; Neale D Ridgway; Gregory D Fairn
Journal:  Sci Rep       Date:  2016-11-02       Impact factor: 4.379

Review 5.  Research advances in kinase enzymes and inhibitors for cardiovascular disease treatment.

Authors:  Rand Shahin; Omar Shaheen; Faris El-Dahiyat; Maha Habash; Sana Saffour
Journal:  Future Sci OA       Date:  2017-08-08

6.  Antikinetoplastid Activity of Indolocarbazoles from Streptomyces sanyensis.

Authors:  Luis Cartuche; Ines Sifaoui; Atteneri López-Arencibia; Carlos J Bethencourt-Estrella; Desirée San Nicolás-Hernández; Jacob Lorenzo-Morales; José E Piñero; Ana R Díaz-Marrero; José J Fernández
Journal:  Biomolecules       Date:  2020-04-24

7.  Actinomycetes from the Red Sea Sponge Coscinoderma mathewsi: Isolation, Diversity, and Potential for Bioactive Compounds Discovery.

Authors:  Yara I Shamikh; Aliaa A El Shamy; Yasser Gaber; Usama Ramadan Abdelmohsen; Hashem A Madkour; Hannes Horn; Hossam M Hassan; Abeer H Elmaidomy; Dalal Hussien M Alkhalifah; Wael N Hozzein
Journal:  Microorganisms       Date:  2020-05-23

8.  Atmospheric Precipitations, Hailstone and Rainwater, as a Novel Source of Streptomyces Producing Bioactive Natural Products.

Authors:  Aida Sarmiento-Vizcaíno; Julia Espadas; Jesús Martín; Alfredo F Braña; Fernando Reyes; Luis A García; Gloria Blanco
Journal:  Front Microbiol       Date:  2018-04-23       Impact factor: 5.640

9.  Antiamoebic Activities of Indolocarbazole Metabolites Isolated from Streptomyces sanyensis Cultures.

Authors:  Luis Cartuche; María Reyes-Batlle; Ines Sifaoui; Iñigo Arberas-Jiménez; José E Piñero; José J Fernández; Jacob Lorenzo-Morales; Ana R Díaz-Marrero
Journal:  Mar Drugs       Date:  2019-10-17       Impact factor: 5.118

10.  Evaluation of Indolocarbazoles from Streptomyces sanyensis as a Novel Source of Therapeutic Agents against the Brain-Eating Amoeba Naegleria fowleri.

Authors:  Aitor Rizo-Liendo; Ines Sifaoui; Luis Cartuche; Iñigo Arberas-Jiménez; María Reyes-Batlle; José J Fernández; José E Piñero; Ana R Díaz-Marrero; Jacob Lorenzo-Morales
Journal:  Microorganisms       Date:  2020-05-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.